Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
about
Expression of receptors for human angiogenin in vascular smooth muscle cellsDivergence in the plasminogen-binding group a streptococcal M protein family: functional conservation of binding site and potential role for immune selection of variantsThe receptor site of the spider toxin PcTx1 on the proton-gated cation channel ASIC1aThe FbaB-type fibronectin-binding protein of Streptococcus pyogenes promotes specific invasion into endothelial cells.Identification of the major phosphorylation sites for protein kinase C in kit/stem cell factor receptor in vitro and in intact cellsAn activated L-selectin mutant with conserved equilibrium binding properties but enhanced ligand recognition under shear flowAge relationships and sex differences in serum levels of pregnenolone and 17-hydroxypregnenolone in healthy subjectsThe prototypical 4.1R-10-kDa domain and the 4.1g-10-kDa paralog mediate fodrin-actin complex formationMapping the charged residues in the second immunoglobulin-like domain of the vascular endothelial growth factor/placenta growth factor receptor Flt-1 required for binding and structural stabilityCharacterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7)Isolation of human pancreastatin fragment containing the active sequence from a glucagonomaActivated human plasma carboxypeptidase B is retained in the blood by binding to alpha2-macroglobulin and pregnancy zone proteinCritical contributions of amino-terminal extracellular domains in agonist binding and activation of secretin and vasoactive intestinal polypeptide receptors. Studies of chimeric receptorsThe trap-like relaxin-binding site of the leucine-rich G-protein-coupled receptor 7The retinal pigment epithelial-specific 11-cis retinol dehydrogenase belongs to the family of short chain alcohol dehydrogenasesThe fate of plasma kallikrein in normal and kininogen-deficient ratsGefitinib induces epidermal growth factor receptor dimers which alters the interaction characteristics with ¹²⁵I-EGFComparing the epidermal growth factor interaction with four different cell lines: intriguing effects imply strong dependency of cellular contextA comparison of the surface and secretions of Trichinella pseudospiralis and T. spiralis.Identification of a novel hemolymph peptide that modulates silkworm feeding motivation.Proteolytic degradation of hemoglobin by endogenous lysosomal proteases gives rise to bioactive peptides: hemorphins.Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods.Group A streptococcal growth phase-associated virulence factor regulation by a novel operon (Fas) with homologies to two-component-type regulators requires a small RNA molecule.In-vivo blood-brain barrier transport of a novel adrenocorticotropic hormone analogue, ebiratide, demonstrated by brain microdialysis and capillary depletion methods.Expression of the fibronectin-binding components of Streptococcus pyogenes in Escherichia coli demonstrates that they are proteins.Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice.Crucial role of the CB3-region of collagen IV in PARF-induced acute rheumatic fever.Relationship of raised platelet IgG in thrombocytopenia to total platelet protein content.Selective inhibition of angiotensin receptor signaling through Erk1/2 pathway by a novel peptide.Antibody buffering of a ligand in vivoRational design of aggregation-resistant bioactive peptides: reengineering human calcitonin.Porcine major histocompatibility complex (MHC) class I molecules and analysis of their peptide-binding specificitiesPeptide E and its products, BAM 18 and Leu-enkephalin, in bovine adrenal medulla and cultured chromaffin cells: release in response to stimulation.Isoform specificity among ankyrins. An amphipathic alpha-helix in the divergent regulatory domain of ankyrin-b interacts with the molecular co-chaperone Hdj1/Hsp40.The growth hormone response to insulin induced hypoglycaemia in anorexia nervosa and control underweight or normal subjects.Structures involved in the interaction of Porphyromonas gingivalis fimbriae and human lactoferrin.Characterization of binding specificities of bovine leucocyte class I molecules: impacts for rational epitope discovery.Immunological investigations of Candida albicans in respiratory disease.The effect of intravenous heparin infusions on the thyroid stimulating hormone response to thyrotrophin releasing hormoneProperly timed exposure to central ANG II prevents behavioral sensitization and changes in angiotensin receptor expression.
P2860
Q22009131-0FDDE315-A57A-421F-B453-A18C021D4B50Q24297494-E01E0D2F-13D6-4856-BED1-58970FB7CE24Q24544187-376B0CF2-37B1-46B3-A986-951C12EF301EQ27349319-E14377C7-1BD8-49EB-AA2A-59D6D126EBA0Q28115677-F341FE20-D205-4B72-A6B2-AA811D2B2E8AQ28117130-8C386231-97F4-4A04-AB34-851F2527CB22Q28137637-5B494208-5836-4332-8A72-F4F70CE3AE92Q28207219-599F6C58-021C-43DE-9B1E-38697E6F362BQ28260756-63C2F507-E88F-4621-82C2-8990E3E31452Q28270502-239A1E11-5550-4B7B-A7CC-2ACF1281D094Q28280720-1EB5A9F4-10F9-4629-A755-CA7EF2391C23Q28281712-4C94ED7D-1936-411E-BBA1-A7928BB7D48CQ28303314-FFD7C763-BDE1-40A2-9908-E5B89A8843B4Q28306165-73287E23-26DD-40EB-901B-C716FC52C0E0Q28306316-4ED80A0E-23A7-4502-BB38-AB5771499B86Q28574755-74C840DF-DD64-4BCB-9935-57C2EDABE6A9Q28740473-AE284145-7463-409F-B23A-0FC49F949472Q28743143-85B65003-4D12-42BF-AD99-FFAB5CD8FC56Q30406318-BA4CD832-2984-4C0B-AEC0-A04B80480CD0Q30498258-89F45B0B-9B2D-4E16-BEFC-10C423FD40B1Q30675590-AB2D8EF4-109B-4143-9614-48BD877F65C0Q31146406-C8609E47-CD88-40FD-BD26-AC9C36C179B8Q31795875-5C3673E9-D42D-4729-94B6-1441C0C6892DQ33189702-F2BF9939-BD2C-47CA-81F0-FF043EA4844DQ33324304-8FC775D1-90DB-49BB-971F-264A43BCE002Q33401560-3689912A-9947-40D8-9FB6-4E56EF60F32CQ33413755-6CA792FF-DE87-457C-BBA4-BCB7C7ABA095Q33486386-2AD86ADD-9BD4-4D0D-980F-57ABF1EED6DBQ33704868-0C59F2BA-A4C8-4523-8A29-31DDD6FF468AQ33715292-28EFEDE1-8BA3-4927-B47A-98AC1089CA12Q33895725-5C40ED67-EF13-431B-A94E-8B1D9BFD422CQ33955589-A8E39056-53F6-4741-A3B2-8944FF3B90BDQ34187410-47E95F4E-E31B-4EB1-A600-1C42BDFA10C5Q34312369-ED5876BA-EE7D-4F31-B24D-3D3C34E741B7Q34332341-E373F5DC-A3C0-4EC5-BAFD-71586116FDC7Q34459044-A968BE6F-2986-4E9A-B578-A978B3C024E2Q34476258-F55D8A78-57E6-4674-BA94-E4B33C205898Q34515137-6A379EA5-674A-4B26-926C-5934689A0EFBQ34516947-613E15DC-2E38-439E-A621-D389EEA26659Q34726660-53A116DD-6AEE-497F-91CE-F02C7408B4EF
P2860
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
description
article publié dans la revue scientifique Nature
@fr
scientific article published in Nature
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в Nature в травні 1962
@uk
name
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
@en
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
@nl
type
label
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
@en
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
@nl
prefLabel
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
@en
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
@nl
P356
P1433
P1476
Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific Activity
@en
P2093
F. C. GREENWOOD
W. M. HUNTER
P2888
P304
P356
10.1038/194495A0
P407
P577
1962-05-01T00:00:00Z
P6179
1006221676